Sugi Predict

Sugi Predict / Compounds / SCHEMBL460607

SCHEMBL460607

SCHEMBL460607

NNS(=O)(=O)C=Cc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.56
▸ PTGES2 Q9H7Z7 1/20 0.56
▸ KMT2A Q03164 3/20 0.54
▸ PKM P14618 1/20 0.54
▸ HSP90AA1 P07900 2/20 0.53
▸ HTT P42858 2/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ ALDH1A1 P00352 5/20 0.50
▸ GAA P10253 2/20 0.50
▸ PPARG P37231 2/20 0.48
▸ NFE2L2 Q16236 1/20 0.48
▸ POLB P06746 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1324785 0.83 KMT2A (0.62) LMNAPTGES2KMT2APKMHSP90AA1
SCHEMBL1324810 0.83 KMT2A (0.62) LMNAPTGES2KMT2APKMHSP90AA1
SCHEMBL1324783 0.83 KMT2A (0.62) LMNAPTGES2KMT2APKMHSP90AA1
SCHEMBL12851366 0.79 HTT (0.57) LMNAPTGES2KMT2APKMHSP90AA1
SCHEMBL13889749 0.79 HTT (0.57) LMNAPTGES2KMT2APKMHSP90AA1
SCHEMBL7525628 0.79 HTT (0.57) LMNAPTGES2KMT2APKMHSP90AA1
SCHEMBL1122431 0.78 KMT2A (0.77) LMNAPTGES2KMT2APKMHSP90AA1
SCHEMBL1122427 0.78 KMT2A (0.77) LMNAPTGES2KMT2APKMHSP90AA1
SCHEMBL11536681 0.77 HTT (0.55) LMNAPTGES2KMT2APKMHSP90AA1
SCHEMBL11536684 0.77 HTT (0.55) LMNAPTGES2KMT2APKMHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1218815-A Polystyrene sulfonyl hydrazino dithio formate resin ECOLOGICAL ENVIRONMENT RESEARC (CN) 1999-06-09 — — CN claimed
CN-102603660-B Preparation method of 1H-1,2,3-triazole compound UNIV ZHEJIANG TECHNOLOGY 2014-07-02 — — CN disclosed
US-8653305-B2 Compound having S1P receptor binding potency and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2014-02-18 — — US disclosed
US-20120064060-A1 COMPOUND HAVING S1P RECEPTOR BINDING POTENCY AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-03-15 — — US disclosed
US-8039674-B2 Amino-substituted cyclic compound for EDG-1(endothelial differentiation gene) and/or EDG-6-mediated diseases; transplant rejection, autoimmune diseases, allergies, asthma, multiple organ failure, ischemia, reperfusion injury, lung or liver fibrosis; antitumor agents ONO PHARMACEUTICAL CO., LTD. (JP) 2011-10-18 — — US disclosed
EP-2308562-A2 Azetidine ring compounds and drugs comprising the same Ono Pharmaceutical Co., Ltd. (JP) 2011-04-13 — — EP disclosed
US-7511159-B2 Azetidine ring compounds and drugs comprising the same ONO PHARMACEUTICAL CO., LTD. (JP) 2009-03-31 — — US disclosed
US-20080207584-A1 Compound Having S1P Receptor Binding Potency and Use Thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2008-08-28 — — US disclosed
US-20070135402-A1 Azetidine ring compounds and drugs comprising the same ONO PHARMACEUTICAL CO., LTD. (JP) 2007-06-14 — — US disclosed
EP-1319646-B1 PROCESS FOR PREPARATION OF 3,5-BISALKYLPHENOLS KOWA CO (JP) 2007-04-18 — — EP disclosed
EP-1760071-A1 COMPOUND HAVING S1P RECEPTOR BINDING POTENCY AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2007-03-07 — — EP disclosed
EP-1698375-A1 AZETIDINE RING COMPOUNDS AND DRUGS COMPRISING THE SAME ONO PHARMACEUTICAL CO., LTD. (JP) 2006-09-06 — — EP disclosed
CN-1266169-C Polystyrene sulfinate resin and its preparing method UNIV NANKAI (CN) 2006-07-26 — — CN disclosed
CN-1631909-A Polystyrene sulfinate resin and its preparing method UNIV NANKAI (CN) 2005-06-29 — — CN disclosed
US-6806395-B2 FOR PRODUCING 3,5- DIISOPROPYLPHENOL OR A SIMILAR COMPOUND, WHICH SERVES AS AN INTERMEDIATE FOR PRODUCING ANTI-INFLAMMATORY AGENTS, PESTICIDES, ETC. KOWA CO., LTD. (JP) 2004-10-19 — — US disclosed
US-20040044255-A1 Process for preparation of 3,5-bisalkylphenols KOWA CO., LTD. (JP) 2004-03-04 — — US disclosed
EP-1319646-A1 PROCESS FOR PREPARATION OF 3,5-BISALKYLPHENOLS Kowa Co., Ltd. (JP) 2003-06-18 — — EP disclosed
CN-1075521-C Polystyrene sulfonyl hydrazino dithio formate resin ECOLOGICAL ENVIRONMENT RES CT (CN) 2001-11-28 — — CN disclosed
CN-1218815-A Polystyrene sulfonyl hydrazino dithio formate resin ECOLOGICAL ENVIRONMENT RESEARC (CN) 1999-06-09 — — CN disclosed
CN-1218815-A Polystyrene sulfonyl hydrazino dithio formate resin ECOLOGICAL ENVIRONMENT RESEARC (CN) 1999-06-09 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135402-A1 Azetidine ring compounds and drugs comprising the same EDNRA, LIPG, EDNRB LMNA 1076/4885PTGES2 331/4885KMT2A 2539/4885
US-20120064060-A1 COMPOUND HAVING S1P RECEPTOR BINDING POTENCY AND USE THEREOF S1PR1, S1PR3, EDNRA LMNA 3842/4885PTGES2 760/4885KMT2A 2641/4885
US-20080207584-A1 Compound Having S1P Receptor Binding Potency and Use Thereof S1PR1, EDNRA, S1PR3 LMNA 3904/4885PTGES2 780/4885KMT2A 2410/4885
US-20040044255-A1 Process for preparation of 3,5-bisalkylphenols ACSL3, HACL2, ARL1 LMNA 2714/4885PTGES2 2153/4885KMT2A 2277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.